U.S. CDC reports 194,092 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday reported 6,537,627 cases of the new coronavirus, an increase of 34,597 cases from its previous count, and said the number of deaths had risen by 387 to 194,092.

The CDC’s tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, is as of 4 p.m. ET on Sept. 14 compared with its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting By Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi)

U.S. CDC reports 191,353 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Friday reported 6,381,013 cases of the new coronavirus, an increase of 37,451 cases from its previous count, and said that the number of deaths had risen by 1,091 to 191,353.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 p.m. ET on Sept. 10 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju Samuel)

U.S. CDC reports 190,262 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) said on Thursday the number of deaths due to the new coronavirus had risen by 1,115 to 190,262 and reported 6,343,562 cases, an increase of 32,899 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on Sept. 9 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Trisha Roy in Bengaluru; Editing by Ramakrishnan M.)

U.S. CDC reports 188,688 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday the number of deaths due to the new coronavirus had risen by 175 to 188,688 and reported 6,287,362 cases, an increase of 26,146 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on Sept. 7 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Trisha Roy in Bengaluru; Editing by Aditya Soni)

U.S. CDC reports 186,173 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Friday said the number of deaths due to the new coronavirus had risen by 1,081 to 186,173 and reported 6,132,074 cases, an increase of 44,671 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 p.m. ET on Sept. 3 compared with its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Vishwadha Chander in Bengaluru; Editing by Vinay Dwivedi)

U.S. coronavirus deaths projected to more than double to 410,000 by January

By Daniel Trotta

(Reuters) – U.S. deaths from the coronavirus will reach 410,000 by the end of the year, more than double the current death toll, and deaths could soar to 3,000 per day in December, the University of Washington’s health institute forecast on Friday.

Deaths could be reduced by 30% if more Americans wore face masks as epidemiologists have advised, but mask-wearing is declining, the university’s Institute for Health Metrics and Evaluation said.

The U.S. death rate projected by the IHME model, which has been cited by the White House Coronavirus Task Force, would more than triple the current death rate of some 850 per day.

“We expect the daily death rate in the United States, because of seasonality and declining vigilance of the public, to reach nearly 3,000 a day in December,” the institute, which bills itself as an independent research center, said in an update of its periodic forecasts.

“Cumulative deaths expected by January 1 are 410,000; this is 225,000 deaths from now until the end of the year,” the institute said.

It previously projected 317,697 deaths by Dec. 1.

The model’s outlook for the world was even more dire, with deaths projected to triple to 2.8 million by Jan. 1, 2021.

The United States, which has the world’s third largest population, leads the planet with more than 186,000 COVID-19 deaths and 6.1 million coronavirus infections.

The institute made waves earlier this year when its aggressive forecasts contrasted with President Donald Trump’s repeated statements that the coronavirus would disappear. But deaths have surpassed some of the institute’s dire predictions, which have been frequently updated to reflect new data, revised assumptions and more sophisticated information sources.

The U.S. Centers for Disease Control and Prevention issues forecasts only four weeks in advance, and its latest estimate is for 200,000 to 211,000 dead by Sept. 26.

But the institute said with so many Americans still refusing to wear masks, there remains “an extraordinary opportunity” to save lives.

“Increasing mask use to the levels seen in Singapore would decrease the cumulative death toll to 288,000, or 122,000 lives saved compared to the reference scenario,” it said.

“Mask use continues to decline from a peak in early August. Declines are notable throughout the Midwest, including in some states such as Illinois and Iowa with increasing case numbers,” the report said.

Although U.S. infections have declined to around 45,000 per day from a peak of around 70,000 per day in July, COVID-19 was the second leading cause of death, the institute said. That would place it behind only heart disease, having surpassed cancer as a cause of death in the United States.

Infection rates have recently fallen in large states such as Texas, Florida and California, leading to the national decline in cases.

But 10 states, many of them in the Midwest, still average more than one secondary case per infected person, an indication of rapid spreading, the report said.

(Reporting by Daniel Trotta; Additional reporting by Peter Szekely; Editing by Howard Goller)

U.S. CDC reports 185,092 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Thursday said the number of deaths due to the new coronavirus had risen by 1,009 to 185,092 and reported 6,087,403 cases, an increase of 39,711 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 p.m. ET on Sept. 2 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Dania Nadeem in Bengaluru; Editing by Ramakrishnan M.)

U.S. CDC tells states to prep for COVID-19 vaccine distribution as soon as late October

By Manojna Maddipatla

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) has asked state public health officials to prepare to distribute a potential coronavirus vaccine to high-risk groups as soon as late October, documents published by the agency showed on Wednesday.

The timing of a vaccine has taken on political importance as U.S. President Donald Trump seeks re-election in November, after committing billions of federal dollars to develop a vaccine to prevent COVID-19, which has killed more than 180,000 Americans.

“For the purpose of initial planning, CDC provided states with certain planning assumptions as they work on state specific plans for vaccine distribution, including possibly having limited quantities of vaccines in October and November,” a CDC spokeswoman told Reuters.

The New York Times had earlier reported that the CDC had contacted officials in all 50 states and five large cities with the planning information.

The country’s top infectious disease expert Anthony Fauci earlier on Wednesday said on MSNBC that based on the patient enrollment rate in COVID-19 vaccine trials underway, there could be enough clinical data to know by November or December that one of the vaccines is safe and effective.

The documents put online by the New York Times showed the CDC is preparing for one or two vaccines for COVID-19 to be available in limited quantities as soon as late October.

The vaccines would be made available free of cost first to high-risk groups including healthcare workers, national security personnel, and nursing home residents and staff, the agency said in the documents.

Regulators around the world have repeatedly said development speed will not compromise vaccine safety, as quicker results would stem from conducting parallel trials that are usually done in sequence. But such reassurances have not convinced everyone.

Preliminary results of a survey conducted over the last three months in 19 countries showed that only about 70% of British and U.S. respondents would take a COVID-19 vaccine if available, Scott Ratzan, co-leader of a group called Business Partners to Convince, told Reuters in August.

Drug developers including Moderna Inc., AstraZeneca Plc and Pfizer Inc. are leading the race to develop a safe and effective vaccine for the respiratory illness.

The CDC documents describe two vaccine candidates that must be stored at temperatures of minus 70 and minus 20 degrees Celsius. Those storage requirements match profiles of candidates from Pfizer and Moderna.

Last month, the U.S. health department said the CDC was executing an existing contract option with McKesson Corp. to support potential vaccine distribution.

CDC Director Robert Redfield has asked state governors to expedite McKesson’s requests for building vaccine distribution centers and to consider waiving requirements that would stop them from becoming fully operational by Nov. 1, according to a recent letter obtained by Reuters.

(Reporting by Manojna Maddipatla in Bengaluru and Deena Beasley in Los Angeles; Editing by Maju Samuel, Tom Brown and Subhranshu Sahu)

U.S. CDC reports 184,083 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Wednesday said the number of deaths due to the new coronavirus had risen by 1,033 to 184,083 and reported 6,047,692 cases, an increase of 43,249 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 p.m. ET on Sept. 1 compared with its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Dania Nadeem in Bengaluru; Editing by Vinay Dwivedi)

U.S. to send millions of rapid COVID-19 tests to states to support school reopening, other tasks

By Carl O’Donnell and Vishwadha Chander

(Reuters) – The U.S. government will send an “overwhelming majority” of the rapid COVID-19 tests it purchased from Abbott Laboratories last week to governors of states and territories to support school re-openings and other critical tasks, an administration official said at a press briefing.

Other top priorities for the newly purchased tests include day care centers, first responders, and “critical infrastructure,” said Admiral Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services.

The U.S. government purchased 150 million rapid antigen tests for COVID-19 from Abbott in a roughly $750 million deal.

The portable tests can deliver results within 15 minutes and will sell for $5. They require no additional equipment, and can use a less invasive nasal swab than traditional lab tests.

Antigen tests are cheaper and faster than molecular diagnostic tests, but somewhat more likely to fail to identify positive cases of the virus than lab-based diagnostic tests.

U.S. President Donald Trump has repeatedly pushed for schools to reopen, but most of the country’s largest school districts have said they would start the school year with online classes, as states across the country have battled a spike in cases over the summer.

Girior also said the Centers for Disease Control and Prevention (CDC) still supports testing asymptomatic individuals for COVID-19 who are prioritized by local health officials or in high risk populations. Last week, the CDC sparked outcry among many public health officials when it said testing some asymptomatic people may not be necessary.

The U.S. government has conducted 85 million COVID-19 tests so far with a positivity rate of just over 5%, Girior said. The mean turnaround time is 2.27 days.

(Reporting by Carl O’Donnell; Editing by Chris Reese and David Gregorio)